Lisinopril Renewal tablets are indicated for the treatment of:

• Hypertension (high blood pressure): as monotherapy or in combination with other antihypertensive agents.
• Heart failure: to improve symptoms, increase survival, and reduce the risk of hospitalization.
• Acute myocardial infarction (heart attack): in hemodynamically stable patients within 24 hours of the onset of symptoms, to improve survival.

 

• Hypersensitivity to lisinopril or any component of the formulation.
• History of angioedema related to previous treatment with an ACE inhibitor.
• Pregnancy (second and third trimesters): lisinopril can cause fetal harm or death when administered during pregnancy.

 

• The dosage of Lisinopril Renewal tablets varies depending on the patient's medical condition and response to treatment.
• For hypertension, the usual starting dose is 10 mg once daily, with subsequent dose adjustments based on blood pressure response.
• For heart failure, the initial dose is typically 2.5-5 mg once daily, with gradual titration to the target maintenance dose of 20-40 mg once daily.
• For acute myocardial infarction, the initial dose is 5 mg within the first 24 hours, followed by 5 mg after 24 hours, 10 mg after 48 hours, and then 10 mg once daily for 6 weeks.

Common side effects of lisinopril may include:

• Dizziness
• Headache
• Fatigue
• Hypotension (low blood pressure)
• Cough
• Nausea
• Hyperkalemia (high potassium levels)
• Renal impairment

 

• Lisinopril should be used with caution in patients with renal impairment, as it can further deteriorate kidney function.
• Patients should be monitored for signs of angioedema, especially during the first few weeks of treatment.
• Lisinopril may interact with other medications, so it is important to inform the healthcare provider about all current medications and medical conditions before starting treatment.
• Abrupt discontinuation of lisinopril may result in rebound hypertension, so gradual tapering of the dose may be necessary if discontinuation is required.

Store Lisinopril Renewal tablets at room temperature (15-30°C) in a dry place, away from moisture and heat. Keep out of reach of children.